| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Proceedings of the National Academy of Sciences of the United States of America | 1998 | 1.5K |
| Differential prognostic impact of comorbidity | Journal of Clinical Oncology | 2004 | 265 |
| ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia | Blood | 2005 | 205 |
| Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells | Journal of Clinical Investigation | 1998 | 192 |
| Acquired CD40-ligand deficiency in chronic lymphocytic leukemia | Nature Medicine | 1997 | 171 |
| Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring | Nature | 2019 | 155 |
| A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia | Leukemia and Lymphoma | 2015 | 125 |
| Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases | Cancer | 1982 | 107 |
| Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics | International Journal of Cancer | 2006 | 105 |
| Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma | Nature | 2016 | 84 |
| BCR-ABL-transformed GMP as myeloid leukemic stem cells | Proceedings of the National Academy of Sciences of the United States of America | 2008 | 76 |
| Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis | Proceedings of the National Academy of Sciences of the United States of America | 2017 | 75 |
| Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer | Journal of Cellular Biochemistry | 2012 | 71 |
| Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI | Lung Cancer | 2015 | 63 |
| Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy | Nature Communications | 2020 | 62 |
| Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers | Cancer Research | 2017 | 61 |
| Radiation-induced lung injury in vivo: expression of transforming growth factor-beta precedes fibrosis | Inflammation | 1996 | 59 |
| Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia | Journal of the National Cancer Institute | 2019 | 50 |
| Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians | Journal of Emergency Medicine | 2018 | 45 |
| Monoclonal antibodies in the treatment of cancer | Critical Reviews in Oncology/Hematology | 1984 | 39 |
| Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department | Annals of Emergency Medicine | 2017 | 35 |
| Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS) | Brachytherapy | 2019 | 32 |
| TGF-beta: a master immune regulator | Expert Opinion on Therapeutic Targets | 2020 | 32 |
| Integrin αvβ5 Internalizes Zika Virus during Neural Stem Cells Infection and Provides a Promising Target for Antiviral Therapy | Cell Reports | 2020 | 32 |
| Bortezomib is effective in primary plasma cell leukemia | Leukemia and Lymphoma | 2006 | 30 |
